US Stock MarketDetailed Quotes

TRAW Traws Pharma

Watchlist
  • 5.282
  • +0.072+1.37%
Trading Dec 19 11:42 ET
15.98MMarket Cap-0.04P/E (TTM)

Traws Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
Operating revenue
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
Cost of revenue
Gross profit
Operating expense
66.98%8.59M
27.30%5.94M
-14.94%5.27M
3.38%20.52M
-21.97%4.52M
-9.69%5.15M
11.73%4.67M
47.87%6.19M
18.72%19.85M
51.61%5.79M
Selling and administrative expenses
29.56%3.48M
-10.58%1.98M
58.83%3.36M
7.66%9.09M
3.32%2.08M
27.60%2.69M
3.37%2.21M
-3.34%2.11M
-10.38%8.45M
-2.75%2.02M
-General and administrative expense
29.56%3.48M
-10.58%1.98M
58.83%3.36M
7.66%9.09M
3.32%2.08M
27.60%2.69M
3.37%2.21M
-3.34%2.11M
-10.38%8.45M
-2.75%2.02M
Research and development costs
107.85%5.11M
61.40%3.96M
-53.14%1.91M
0.21%11.43M
-35.49%2.43M
-31.53%2.46M
20.51%2.46M
103.80%4.08M
56.31%11.41M
116.22%3.77M
Operating profit
-67.73%-8.54M
-27.64%-5.88M
15.07%-5.21M
-3.42%-20.3M
22.18%-4.46M
9.79%-5.09M
-11.89%-4.61M
-48.52%-6.14M
-18.98%-19.63M
-52.38%-5.73M
Net non-operating interest income expense
Other net income (expense)
-82.57%61K
-32,671.94%-117.26M
-36.74%229K
103.62%1.35M
-11.46%278K
44.03%350K
275.00%360K
3,520.00%362K
99.10%663K
31,500.00%314K
Special income (charges)
--0
---117.46M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
----
--117.46M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-82.57%61K
-43.06%205K
-36.74%229K
103.62%1.35M
-11.46%278K
44.03%350K
275.00%360K
3,520.00%362K
5,425.00%663K
31,500.00%314K
Income before tax
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
Income tax
Net income
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
Net income continuous Operations
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
Minority interest income
Net income attributable to the parent company
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
Basic earnings per share
-56.21%-8.81
-2,335.00%-121.75
14.29%-6
1.10%-22.5
24.46%-4.91
13.23%-5.64
-5.26%-5
-40.00%-7
5.21%-22.75
-62.50%-6.5
Diluted earnings per share
-56.21%-8.81
-2,335.00%-121.75
14.29%-6
1.10%-22.5
24.46%-4.91
13.23%-5.64
-5.26%-5
-40.00%-7
5.21%-22.75
-62.50%-6.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K
Operating revenue 0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K
Cost of revenue
Gross profit
Operating expense 66.98%8.59M27.30%5.94M-14.94%5.27M3.38%20.52M-21.97%4.52M-9.69%5.15M11.73%4.67M47.87%6.19M18.72%19.85M51.61%5.79M
Selling and administrative expenses 29.56%3.48M-10.58%1.98M58.83%3.36M7.66%9.09M3.32%2.08M27.60%2.69M3.37%2.21M-3.34%2.11M-10.38%8.45M-2.75%2.02M
-General and administrative expense 29.56%3.48M-10.58%1.98M58.83%3.36M7.66%9.09M3.32%2.08M27.60%2.69M3.37%2.21M-3.34%2.11M-10.38%8.45M-2.75%2.02M
Research and development costs 107.85%5.11M61.40%3.96M-53.14%1.91M0.21%11.43M-35.49%2.43M-31.53%2.46M20.51%2.46M103.80%4.08M56.31%11.41M116.22%3.77M
Operating profit -67.73%-8.54M-27.64%-5.88M15.07%-5.21M-3.42%-20.3M22.18%-4.46M9.79%-5.09M-11.89%-4.61M-48.52%-6.14M-18.98%-19.63M-52.38%-5.73M
Net non-operating interest income expense
Other net income (expense) -82.57%61K-32,671.94%-117.26M-36.74%229K103.62%1.35M-11.46%278K44.03%350K275.00%360K3,520.00%362K99.10%663K31,500.00%314K
Special income (charges) --0---117.46M--------------0--0------------
-Less:Other special charges ------117.46M--------------------------------
Other non- operating income (expenses) -82.57%61K-43.06%205K-36.74%229K103.62%1.35M-11.46%278K44.03%350K275.00%360K3,520.00%362K5,425.00%663K31,500.00%314K
Income before tax -78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M
Income tax
Net income -78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M
Net income continuous Operations -78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M
Minority interest income
Net income attributable to the parent company -78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M
Basic earnings per share -56.21%-8.81-2,335.00%-121.7514.29%-61.10%-22.524.46%-4.9113.23%-5.64-5.26%-5-40.00%-75.21%-22.75-62.50%-6.5
Diluted earnings per share -56.21%-8.81-2,335.00%-121.7514.29%-61.10%-22.524.46%-4.9113.23%-5.64-5.26%-5-40.00%-75.21%-22.75-62.50%-6.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Oracle
ORCL
+2.96%
Amazon
AMZN
+2.31%
Alphabet-A
GOOGL
+1.62%
Petroleo Brasileiro SA Petrobras
PBR
+1.55%
Meta Platforms
META
+1.57%

Unlock the Full List